Multifunctional aptamer-DNA nanostructures for tumor-targeted killing

Yung Chang (Inventor), Hao Yan (Inventor)

Research output: Patent

Abstract

Despite decades of research, cancer remains one of todays most pressing health concerns. Traditional treatment approaches such as radiation therapy and chemotherapy can cause systemic toxicity and become ineffective when resistant tumors emerge. Recently, anticancer strategies have focused on drugs which specifically target tumor-related biological molecules. Recognizing cancer cells and inducing apoptosis is a promising approach to tumor therapy. Researchers at the Biodesign Institute of Arizona State University have developed a selection method for ligands to tumor cell-specific markers and death receptors on the tumor cell. The two ligands are screened from an aptamer library for high affinity and specificity to their targets. Multimeric structures of both aptamers are then synthesized and assembled to coordinate presentation to the cell and induce cell death. Potential Applications Cancer diagnostic Anticancer therapeutic Benefits and Advantages Lower systemic toxicity due to targeted delivery Assembly provides spatial organization of binding aptamers and increased avidity to target Scalable feature of the DNA-nanostructure platform makes it possible to incorporate additional biomolecules to enhance tumor-targeted killing Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Yan's departmental webpage Dr. Yan's Laboratory webpage Dr. Chang's directory webpage Dr. Chang's departmental webpage
Original languageEnglish (US)
StatePublished - Apr 3 2009

Fingerprint

Nucleotide Aptamers
Nanostructures
Neoplasms
Inventors
Ligands
Directories
Death Domain Receptors
Research
Libraries
Cell Death
Radiotherapy
Therapeutics
Research Personnel
Apoptosis
Drug Therapy

Cite this

@misc{8e0b3270254f4d4f9f411abbc993d32d,
title = "Multifunctional aptamer-DNA nanostructures for tumor-targeted killing",
abstract = "Despite decades of research, cancer remains one of todays most pressing health concerns. Traditional treatment approaches such as radiation therapy and chemotherapy can cause systemic toxicity and become ineffective when resistant tumors emerge. Recently, anticancer strategies have focused on drugs which specifically target tumor-related biological molecules. Recognizing cancer cells and inducing apoptosis is a promising approach to tumor therapy. Researchers at the Biodesign Institute of Arizona State University have developed a selection method for ligands to tumor cell-specific markers and death receptors on the tumor cell. The two ligands are screened from an aptamer library for high affinity and specificity to their targets. Multimeric structures of both aptamers are then synthesized and assembled to coordinate presentation to the cell and induce cell death. Potential Applications Cancer diagnostic Anticancer therapeutic Benefits and Advantages Lower systemic toxicity due to targeted delivery Assembly provides spatial organization of binding aptamers and increased avidity to target Scalable feature of the DNA-nanostructure platform makes it possible to incorporate additional biomolecules to enhance tumor-targeted killing Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Yan's departmental webpage Dr. Yan's Laboratory webpage Dr. Chang's directory webpage Dr. Chang's departmental webpage",
author = "Yung Chang and Hao Yan",
year = "2009",
month = "4",
day = "3",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Multifunctional aptamer-DNA nanostructures for tumor-targeted killing

AU - Chang, Yung

AU - Yan, Hao

PY - 2009/4/3

Y1 - 2009/4/3

N2 - Despite decades of research, cancer remains one of todays most pressing health concerns. Traditional treatment approaches such as radiation therapy and chemotherapy can cause systemic toxicity and become ineffective when resistant tumors emerge. Recently, anticancer strategies have focused on drugs which specifically target tumor-related biological molecules. Recognizing cancer cells and inducing apoptosis is a promising approach to tumor therapy. Researchers at the Biodesign Institute of Arizona State University have developed a selection method for ligands to tumor cell-specific markers and death receptors on the tumor cell. The two ligands are screened from an aptamer library for high affinity and specificity to their targets. Multimeric structures of both aptamers are then synthesized and assembled to coordinate presentation to the cell and induce cell death. Potential Applications Cancer diagnostic Anticancer therapeutic Benefits and Advantages Lower systemic toxicity due to targeted delivery Assembly provides spatial organization of binding aptamers and increased avidity to target Scalable feature of the DNA-nanostructure platform makes it possible to incorporate additional biomolecules to enhance tumor-targeted killing Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Yan's departmental webpage Dr. Yan's Laboratory webpage Dr. Chang's directory webpage Dr. Chang's departmental webpage

AB - Despite decades of research, cancer remains one of todays most pressing health concerns. Traditional treatment approaches such as radiation therapy and chemotherapy can cause systemic toxicity and become ineffective when resistant tumors emerge. Recently, anticancer strategies have focused on drugs which specifically target tumor-related biological molecules. Recognizing cancer cells and inducing apoptosis is a promising approach to tumor therapy. Researchers at the Biodesign Institute of Arizona State University have developed a selection method for ligands to tumor cell-specific markers and death receptors on the tumor cell. The two ligands are screened from an aptamer library for high affinity and specificity to their targets. Multimeric structures of both aptamers are then synthesized and assembled to coordinate presentation to the cell and induce cell death. Potential Applications Cancer diagnostic Anticancer therapeutic Benefits and Advantages Lower systemic toxicity due to targeted delivery Assembly provides spatial organization of binding aptamers and increased avidity to target Scalable feature of the DNA-nanostructure platform makes it possible to incorporate additional biomolecules to enhance tumor-targeted killing Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Yan's departmental webpage Dr. Yan's Laboratory webpage Dr. Chang's directory webpage Dr. Chang's departmental webpage

M3 - Patent

ER -